Preclinical efficacy data yields better clinical results and ensures the regulator’s expediency. Our design team will work closely with you to determine what is relevant, from morphological and biochemical changes to full-spectrum efficacy, toxicology, and monitoring of your trials.

We use only suitable in vitro application for each tested drug to optimize the outcome of the study, such as cell culture study will determine the affect of the novel drug, pre, during and post clinical testing. Our testing is focusing on using a combination of two approaches genomic testing and biomarkers. In the simplest terms, our translational studies bring certitude to “go or no-go” decisions and help de-risk drug development programs.